dc.contributor.author | Fernández-de-las-Peñas, César | |
dc.contributor.author | Cuadrado, Maria L. | |
dc.contributor.author | Gómez-Mayordomo, Victor | |
dc.contributor.author | Torres-Macho, Juan | |
dc.contributor.author | Pellicer-Valero, Oscar J. | |
dc.contributor.author | Martín-Guerrero, José D. | |
dc.contributor.author | Arendt-Nielsen, Lars | |
dc.date.accessioned | 2023-09-19T10:40:45Z | |
dc.date.available | 2023-09-19T10:40:45Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Fernández-de-las-Peñas, C, Cuadrado, ML, Gómez-Mayordomo, V, et al. Headache as a COVID-19 onset symptom and post-COVID-19 symptom in hospitalized COVID-19 survivors infected with the Wuhan, Alpha, or Delta SARS-CoV-2 variants. Headache. 2022; 62: 1148-1152. doi: 10.1111/head.14398 | es |
dc.identifier.issn | 1526-4610 | |
dc.identifier.uri | https://hdl.handle.net/10115/24360 | |
dc.description | © 2022 The Authors. Headache: The Journal of Head and Face Pain published by Wiley Periodicals LLC on behalf of American Headache Society.https://doi.org/10.1111/head.14398 | es |
dc.description.abstract | ObjectiveThis study looked at differences in the presence of headache as an onset symptom of coronavirus disease 2019 (COVID-19) and as a post-COVID-19 symptom in individuals previously hospitalized owing to infection with the Wuhan, Alpha, or Delta variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).BackgroundHeadache can be present in up to 50% of individuals during the acute phase of SARS-CoV-2 infection and in 10% of subjects during the post-COVID-19 phase. There are no data on differences in the occurrence of headache in the acute- and post-COVID-19 phase according to the SARS-CoV-2 variants.MethodsA cross-sectional cohort study was conducted. Unvaccinated subjects previously hospitalized for COVID-19 caused by the Wuhan (n = 201), Alpha (n = 211), or Delta (n = 202) SARS-CoV-2 variants were scheduled for a telephone interview 6 months after hospital discharge. Hospitalization data were collected from hospital medical records.ResultsThe presence of headache as a COVID-19 onset symptom at hospitalization was higher in subjects with the Delta variant (66/202, 32.7%) than in those infected with the Wuhan (42/201, 20.9%; odds ratio [OR] 1.83, 95% confidence interval [CI] 1.17–2.88) or Alpha (25/211, 11.8%; OR 3.61, 95% CI, 2.16–6.01) variants. The prevalence of post-COVID-19 headache 6 months after hospital discharge was higher in individuals infected with the Delta variant (26/202, 12.9%) than in those infected with the Wuhan (11/201, 5.5%; OR 2.52, 95% CI 1.22–5.31) or Alpha (eight of 211, 3.8%; OR 3.74, 95% CI 1.65–8.49) variants. The presence of headache as a COVID-19 onset symptom was associated with post-COVID-19 headache in subjects infected with the Wuhan (OR 7.75, 95% CI 2.15–27.93) and Delta variants (OR 2.78, 95% CI 1.20–6.42) but not with the Alpha variant (OR 2.60, 95% CI 0.49–13.69).ConclusionHeadache was a common symptom in both the acute- and post-COVID-19 phase in subjects infected with the Wuhan, Alpha, and Delta variants but mostly in those infected with the Delta variant. | es |
dc.language.iso | eng | es |
dc.publisher | Wiley | es |
dc.rights | Atribución-NoComercial 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.subject | Medicina | es |
dc.title | Headache as a COVID-19 onset symptom and post-COVID-19 symptom in hospitalized COVID-19 survivors infected with the Wuhan, Alpha, or Delta SARS-CoV-2 variants | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.doi | 10.1111/head.14398 | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |